
1. acta paediatr. 1998 mar;87(3):336-8.

immunogenicity hepatitis b vaccine term preterm infants.

belloni c(1), chirico g, pistorio a, orsolini p, tinelli c, rondini g.

author information: 
(1)division neonatal intensive care, irccs policlinico san matteo, pavia,
italy.

comment in
    acta paediatr. 1998 oct;87(10):1100-1.

some studies suggested decreased seroconversion rates might found in
premature infants low birthweight (< 2000g) following administration of
hepatitis b vaccine birth. aim present investigation to
evaluate possible differences seropositive rates full-term preterm
infants primary vaccination, particular gestational age or
birthweight low. two-thousand nine neonates born hbsag-negative
mothers vaccinated 10 microg recombinant hepatitis b virus (hbv)
vaccine, may 1991 october 1994. children infections, congenital
malformations serious illnesses excluded. hbv vaccine administered
intramuscularly, fourth day life 1 6 months age. 
1-ml blood sample drawn infant 1 month third vaccine dose
for determination level anti-hbs antibody. response hbv
vaccination evaluated 241 preterm (gestational age <38 weeks) infants 
1727 term neonates. statistical difference observed distribution of
anti-hbs antibody level, either preterm infants (<38 weeks) newborns 
of normal gestational age, low birthweight (<2500 g) normal weight
infants. results suggest preterm low birthweight infants (<2500g)
respond hbv vaccine measure normal-term infants.

doi: 10.1080/08035259850157426 
pmid: 9560044  [indexed medline]

